Chemokines and HIV-1 second receptors: The therapeutic connection
- 1 May 1998
- journal article
- review article
- Published by Springer Nature in Nature Medicine
- Vol. 4 (5) , 563-568
- https://doi.org/10.1038/nm0598-563
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Targeting of HIV- and SIV-Infected Cells by CD4-Chemokine Receptor PseudotypesScience, 1997
- Inhibition of HIV-1 Infection by the β-Chemokine MDCScience, 1997
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4The Journal of Experimental Medicine, 1997
- A CXCR4/CD4 Pseudotype Rhabdovirus That Selectively Infects HIV-1 Envelope Protein-Expressing CellsCell, 1997
- Harnessing Viral Devices as Pharmaceuticals: Fighting HIV-1's Fire with FireCell, 1997
- Intra- and Extracellular Immunization Against HIV-1 Infection with Lymphocytes Transduced with an AAV Vector Expressing a Human Anti-gp120 AntibodyHuman Gene Therapy, 1996
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesPublished by Elsevier ,1996
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion CofactorsCell, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995